Satwik Drugs Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 04-01-2025
- Paid Up Capital ₹ 5.58 Cr
as on 04-01-2025
- Company Age 37 Year, 11 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 23.87 Cr
as on 04-01-2025
- Satisfied Charges ₹ 2.50 Cr
as on 04-01-2025
About Satwik Drugs
The Corporate was formerly known as Satwik Drugs Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.58 Cr.
The company currently has active open charges totaling ₹23.87 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nikunj Kanakia, Pulin Goradia, and Prakash Rawal serve as directors at the Company.
- CIN/LLPIN
U24239MH1987PLC194811
- Company No.
194811
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Jan 1987
- Date of AGM
07 Jun 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Satwik Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikunj Kanakia  | Director | 07-Jun-2008 | Current |
| Pulin Goradia | Additional Director | 01-Oct-2009 | Current |
| Prakash Rawal | Director | 07-Jun-2008 | Current |
Financial Performance of Satwik Drugs.
Enhance accessibility to Satwik Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Satwik Drugs?
Unlock access to Satwik Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Srinivas Chemical Industries Private LimitedActive 45 years 9 monthsNikunj Kanakia and Prakash Rawal are mutual person
- Om Shree Pharmachem Private LimitedActive 25 years 4 months
Nikunj Kanakia and Pulin Goradia are mutual person
- Primetime Tours And Travels Private LimitedActive 25 years 1 month
Nikunj Kanakia is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sate Bank Of Mysore Creation Date: 04 Oct 1995 | ₹21.25 Cr | Open |
State Bank Of Mysore Creation Date: 04 Oct 1995 | ₹1.80 Cr | Open |
State Bank Of Mysore Creation Date: 02 Jun 1990 | ₹8.24 M | Open |
How Many Employees Work at Satwik Drugs?
Unlock and access historical data on people associated with Satwik Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satwik Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satwik Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
